Hepatic fascioliasis presenting with bile duct obstruction: a case report

Hepatic fascioliasis presenting with bile duct obstruction: a case report

Rachid Lefriyekh¹, Ahmed Bensaad^1,&, Fatimazahra Bensardi¹, Khalid Elhattabi¹, Mounir Bouali¹, Bessam Daif¹, Abdelaziz Fadil¹, Zakaria Jouahari², Tazi Hicham², Aziz Hamdani², Maha Soussi Abdalaoui²

¹Surgical Emergency Unit P35, University Teaching Hospital Ibn Rochd, Casablanca, Morocco, ²Department of Parasitology, University Teaching Hospital Ibn Rochd, Casablanca, Morocco

^&Corresponding author
Ahmed Bensaad, Surgical Emergency Unit P35, University Teaching Hospital Ibn Rochd, Casablanca, Morocco

Introduction    

Biliary fascioliasis is a rare infection of the hepato-biliary system, caused by the trematode Fasciola hepatica. There has been recently a well recognized worldwide risk of fasciola hepatica infection, and it is becoming an important public health problem, with an estimated 2,5 million people infected in about 61 countries [1]. Few cases have been reported in Morocco, in which it is thought that many human cases of fasciola hepatica infections are been underdiagnosed. We report a case of biliary fascioliasis in its chronique phase, diagnosed on magnetic resonance imaging (MRI) as a hilar cholangiocarcinoma, for which surgery was indicated, as the biliary sepsis could not be controlled.

Patient and observation     

A 40-year-old woman who had a right upper quadrant (RUQ) pain and discomfort for several months was referred to our general surgery department with a suspected cholangiocarcinoma diagnosis. Her main complaint was a mild jaundice, fever, and pain in the RUQ of the abdomen. She had a history of cholelithiasis treated uneventfully with a laparoscopic cholecystectomy. No upper gastrointestinal bleeding, hematochezia, facial rash, itching, or generalized pruritus were present. Abdominal ultrasound revealed mild intra-hepatic biliary dilatation, with bile wall thickening, and no stones were observed. Blood tests revealed no eosinophilia (350 /microliter), while asparate aminotransferase and alanine aminotransferase values were two times the upper limit, 68IU/l and 100IU/L respectively and; Gamma glutamyl-transferase was six times greater (300IU/l). Total bilirubin and direct bilirubin levels were ten and seven times the upper limit, 106mg/l and 80mg/l respectively. Tumor markers were within the normal range. (CA 19.9: 30U/ml; CEA: 3.9U/ml) Since no definite diagnosis could be reached on ultrasonography, magnetic resonance imaging (MRI) was used and a diagnosis of hilar cholangiocarcinoma was suspected (Figure 1). Given the uncontrolled sepsis developed by our patient, surgery was indicated and an intraoperative diagnosis of hepatic fascioliasis was made (Figure 2). The biliary tree was evacuated from mobile parasites instrumentally and the CBD was sutured over a T-tube. Triclabendazole 10mg/Kg/day was successfully used on a single dose regimen. Final cholangiogram realized on the Post-operative day 15 showed no filling defects, and the T-tube was removed. The patient has remained asymptomatic for 4 months.

Discussion     

Fascioliasis is a zoonotic infection caused by a trematode of the liver, fasciola hepatica. Adult large flukes of Fascioliasis are flat worms; measuring up to 2.0 to 4.0 cm long, 1 to 1.5 cm wide. Humans are considered accidental hosts and the infection cycle starts with the ingestion of contaminated water or vegetales containing the larvae [2]. Metarcercariae excyst in the host's duodenum; and due to its invasive nature, it perforates the peritoneum and Glisson's capsule, reaching the biliary ducts through the liver parenchyma. The disease occurs in two phases: the hepatic phase, lasting 3 to 5 months, during which the young fluke penetrates the liver, symptoms of this phase include prolonged fever, hepatomegaly causing right upper quadrant abdominal pain and eosinophilia. Other non specific manifestations are anorexia, weight loss, urticaria and lymphadenopathies. The biliary or chronic phase, represented by the migration from venous radicals into the biliary tree, begins after 6 months. Half of the patients are asymptomatic, and very few cases develop features of biliary tree obstruction, as those presented in this case [2,3]. Ultrasonographic (USG) findings are generally not specific, and may show heterogeneity of the liver parenchyma and some hypoechoic nodules in the acute phase. During the biliary phase, USG findings are those of biliary obstruction, mainly biliary dilatation and in some cases bile wall thickening. Although other imaging possibilities, including computed tomography (CT) and MRI have both equally good diagnosis value, CT is a more appropriate diagnostic tool, identifying the classic "tunnels and caves sign" which correspond to the path of migration of the F. hepatica from the Glisson capsule deep into the hepatic parenchyma [1,4,5]. Final diagnosis can be made with microscopic identification of the ova in the stool and the exact diag¬nosis can be made with the serological tests [6]. Comparatively to other case reports of human fascioliasis in the literature, cases that were diagnosed intra-operatively are very rare, and this case shows that a surgical approach can be necessary in some complicated situations. More often, the biliary phase of the fascioliasis is at best managed, when the diagnosis is made before surgery, with ERCP and sphincterotomy [1]. A single dose of Triclabendazole (TCBZ), 10-20 mg/kg/day, is actually the recommended treatment for fascioliasis, some authors consider the response to this treatment as a criterion for the diagnosis to be made. While this therapy is enough on a single dose regimen, multiple doses may be required in some patients with persistent infection [7].

Conclusion     

A high index of suspicion is necessary for all cases of obstructive jaundice, especially in areas in which human fascioliasis infection is repeatedly reported.

Competing interests     

The authors declare no competing interest.

Authors’ contributions     

All authors have read and approved the final version of the manuscript.

Acknowledgments     

The authors would like to thank LHAROUI Maha for reviewing the manuscript.

Figures     

Figure 1: magnetic retrograde cholangiopan¬creatography (MRCP) revealing dilatation of the intrahepatic bile ducts with filling defect of the upper-portion of the common bile duct

Figure 2: fasciola hepatica adult worm

References     

1. Gulsen MT, Savas MC, Koruk M, Kadayifci A, Demirci F. Fascioliasis: a report of five cases presenting with common bile duct obstruction. Neth J Med. janv 2006;64(1):17-9. PubMed | Google Scholar


2. Mas-Coma S, Valero MA, Bargues MD. Fascioliasis. Adv Exp Med Biol. 2014;766:77-114. PubMed | Google Scholar


3. Losada H, Hirsch M, Guzmán P, Fonseca F, Hofmann E, Alanís M. Fascioliasis simulating an intrahepatic cholangiocarcinoma-Case report with imaging and pathology correlation. Hepatobiliary Surg Nutr. févr 2015;4(1):E1-7. PubMed | Google Scholar


4. Fica A, Dabanch J, Farias C, Castro M, Jercic MI, Weitzel T. Acute fascioliasis--clinical and epidemiological features of four patients in Chile. Clin Microbiol Infect. 2012 Jan;18(1):91-6. PubMed | Google Scholar


5. Lim JH, Mairiang E, Ahn GH. Biliary parasitic diseases including clonorchiasis, opisthorchiasis and fascioliasis. Abdom Imaging. avr 2008;33(2):157-65. PubMed | Google Scholar


6. Oner Vatan A, Mete B, YemiŞen M, Kaya A, Kantarcı F, Saltoğlu N. A case of Fasciola hepatica mimicking sepsis without eosinophilia. Turkiye Parazitol Derg. 2014 Jun;38(2):131-4. PubMed | Google Scholar


7. Na SY, Cha S-W, Lee BH, Lee WC, Choo JW, Kim JN et al. Biliary Fascioliasis Mimicking Focal Cholangiocarcinoma on PET/CT. Korean J Pancreas Biliary Tract. 2006 Janvier ;17(2):37-41. Google Scholar